A Bioequivalence Study of Tobradex AF

Last updated: March 2, 2012
Sponsor: Alcon Research
Overall Status: Completed

Phase

3

Condition

Eye Disorders/infections

Eye Disease

Vision Loss

Treatment

N/A

Clinical Study ID

NCT00362895
C-05-23
  • Ages > 18
  • All Genders

Study Summary

The purpose of the study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 18 or older

  • Other protocol-defined inclusion criteria may apply

Exclusion

Exclusion Criteria:

  • Under 18

  • Other protocol-defined exclusion criteria may apply

Study Design

Total Participants: 995
Study Start date:
April 01, 2006
Estimated Completion Date:
August 31, 2006

Connect with a study center

  • Contact Alcon for Trial Location(s)

    Fort Worth, Texas 76134
    United States

    Site Not Available

  • Houston

    Houston, Texas 77027
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.